Promoting practical action that can help to reduce the environmental impact of respiratory healthcare.
The PCRS has published a calendar of practical steps you can take to make your respiratory…
In-hospital promotion of the oral route and IV to oral switch (IVOST) are key antimicrobial stewardship (AS) initiatives providing benefits for patients, staff and the environment, including reduced…
Created on
30 Aug 2024 •
by
Rodger R, Robertson A, Thompson E, Downie K, Thompson S, Ray G, Chisholm L, Hillson R
CASCADES (Creating a Sustainable Canadian Health System in a Climate Crisis) has published a series of implementation resources for sustainable pharmacy and prescribing practices. At present these…
This report from Healthcare Without Harm highlights successful initiatives across Europe where pharmacists are taking the lead in promoting responsible medicine use, reducing pharmaceutical waste, and…
East London NHS Foundation Trust uses quality improvement as its approach to solving complex problems. This article uses a case study methodology to describe how the trust's programme of…
Created on
27 Aug 2024 •
by
Sarah McAllister, Juliette Brown, Auzewell Chitewe, Francisco Frasquilho, Sian Hodgkinson, Paul Lomax, Adam Toll, Marco Aurelio, Amar Shah
(from abstract)
This studymeasured the extent of active pharmaceutical ingredient (API) contamination in the English national parks by monitoring 54 APIs in 37 rivers across all national parks over…
Case study submitted as part of Lancet Commission call for case studies.
Team members / location: Netherlands, Amsterdam
Issue: Although medications contribute substantially to the…
In December 2021 JDS Evans Pharmacy was successfully selected to enrol in “Greener Primary Care '' pilot scheme. This is a framework and award scheme in Wales that encourages all sectors of primary…
This TOG commentary outlines why the climate and ecological crises should be of particular concern to all those working in women's health, the ways in which our healthcare systems contribute to the…
To scale and spread promotion of the oral route in antimicrobials with high oral bioavailability with the aim of reducing collective IV use by 20% by February 2023 at RAH.
Created on
24 Jul 2024 •
by
R Rodger, S Thompson, A Robertson, C Pender, G Ray, L Chisholm